SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Memecoin on Cronos launched by the Cro Crow community

crow with knife

The community is rallying behind the multichain meme project crow with knife, highlighting its deflationary burn mechanism and organic growth as primary drivers of their bullish sentiment. Discussions are dominated by high-energy engagement and a strong conviction that the token serves as a unique asset within the current meme coin landscape.

Back in 2011, long before “crypto Twitter”, NFTs, or VC-backed chains existed, users of the BitcoinTalk forum came up with a new currency - not to launch a network, but to make fun of btc.... and so: The first memecoin/memecurrency was born.  On May 23, 2011, a Something Awful poster cracked, “Has anyone called them buttcoins yet?”. It was sophomoric and perfect. Within weeks the gag metastasized into Buttcoin.org, a parody blog that described a “peer to peer butt” economy while cataloging mining fiascos, exchange blowups, and MLM-adjacent “innovations”.

Buttcoin

Buttcoin is surging in popularity as the community rallies around its status as a long-standing parody of Bitcoin, with users debating whether its satirical roots give it staying power as a legitimate asset. Supporters are actively pointing to its unique lore, growing holder count, and high-profile endorsements as catalysts, while others remain skeptical, fueling a polarized discussion about its long-term potential in the meme coin space.

VanEck ETF Trust - VanEck Semiconductor ETF

VanEck Semiconductor ETF

The VanEck Semiconductor ETF (SMH) is trending as institutional investors debate whether the sector's aggressive AI-driven rally is facing a distribution phase or a continuation setup. The community is heavily focused on the disconnect between soaring AI infrastructure capex and mounting concerns over data center cancellations, power grid constraints, and valuation premiums.

Avalanche is a high throughput smart contract blockchain&nbsp;platform. Validators secure the network through a proof-of-stake consensus protocol. It is said to be fast, low cost, and environmental friendly.

Avalanche

Avalanche is currently facing intense selling pressure and negative sentiment as investors express frustration over prolonged stagnant price action and its consistent underperformance compared to other assets. The community is actively debating the project's long-term utility versus its speculative nature, while many are focused on the impact of upcoming legislative developments and potential accumulation opportunities during this period of high volatility.

Fresenius Medical Care AG engages in the provision of products and services for individuals with renal diseases. It operates through the Care Enablement and Care Delivery segments. The Care Enablement segment is involved in the healthcare products business including research and development, manufacturing, supply chain, and commercial operations as well as supporting functions, such as regulatory and quality management. The Care Delivery segment focuses on the health care services for the treatment of CKD, ESRD, and other extracorporeal therapies, including value and risk-based care programs. The company was founded on August 5, 1996 and is headquartered in Bad Homburg, Germany.

Fresenius Medical Care AG - ADR

Fresenius Medical Care AG & Co. KGAA

Fresenius Medical Care (FMS) is trending as the community debates the competitive landscape for infection prevention in dialysis, specifically regarding the adoption and impact of antimicrobial catheter lock solutions like Defencath. Investors are actively tracking potential partnerships and the strategic implications of these technologies on facility-level infection metrics as operators strive to improve patient safety outcomes.

DaVita, Inc. engages in the provision of medical care services. It operates through the US Dialysis and Related Lab Services, and Other-Ancillary Services and Strategic Initiatives segments. The US Dialysis and Related Lab Services segment offer kidney dialysis services in the United States for patients suffering from chronic kidney failure. The Other-Ancillary Services and Strategic Initiatives segment consists primarily of pharmacy services, disease management services, vascular access services, clinical research programs, physician services, direct primary care, end stage renal disease seamless care organizations, and comprehensive care. The company was founded in 1994 and is headquartered in Denver, CO.

DaVita Inc

DaVita is currently trending as investors weigh the potential long-term impact of GLP-1 weight-loss drugs on the demand for dialysis services, leading to significant market volatility. While some community members view the sharp price drop as a major overreaction based on distant speculation, others are actively debating the sustainability of the company's business model and debt load in light of emerging medical treatments.

Maulcoin

Maulcoin is trending as its community aggressively rallies behind the project's organic growth and 'join the dark side' branding, with members actively pushing for social engagement and new listings to drive the next wave of price appreciation. Investors are heavily focused on holding through dips and hitting specific market cap milestones that trigger community-wide airdrops, highlighting a strong collective sentiment centered on long-term accumulation rather than short-term gains.

Bitcoin is the world's first decentralized cryptocurrency, created in 2009 by the pseudonymous Satoshi Nakamoto. It enables peer-to-peer electronic cash transactions without intermediaries like banks or governments, operating on a blockchain secured by Proof of Work mining and the SHA-256 cryptographic algorithm.   With a fixed supply cap of 21 million coins and programmatic halvings every four years that reduce miner rewards, Bitcoin is designed as a deflationary digital asset often called "digital gold." Its value stems from solving the double-spending problem without trusted intermediaries, creating the first truly scarce digital asset with censorship resistance and permissionless access that no government, corporation, or individual can control.  Bitcoin operates as a decentralized peer-to-peer network where transactions are recorded on a public ledger called the blockchain, distributed across thousands of computers globally. Transactions are grouped into blocks added approximately every 10 minutes through mining, where specialized computers compete to solve complex mathematical puzzles.   Bitcoin has achieved mainstream adoption through multiple vectors. The January 2024 SEC approval of 11 spot Bitcoin ETFs opened Bitcoin investment to traditional finance participants, and corporations like Strategy (formerly MicroStrategy) are using Bitcoin as a treasury reserve asset to protect against currency debasement, offering MSTR holders amplified exposure to Bitcoin.   The Bitcoin ecosystem continues to evolve with innovations like Ordinals, which emerged in January 2023 to enable NFT-like functionality directly on Bitcoin, and BRC-20 tokens, an experimental standard for creating fungible tokens using Ordinal inscriptions. BTCFi (Bitcoin Finance) represents emerging financial applications extending beyond Bitcoin's traditional role, with protocols like Babylon allowing Bitcoin holders to stake BTC to secure Proof of Stake chains.

Bitcoin

Bitcoin is experiencing heightened volatility as the market reacts to shifting geopolitical tensions between the U.S. and Iran, with traders intensely debating whether current diplomatic stalemate signals a deeper correction or a massive short squeeze. Community sentiment is deeply polarized, with bulls pointing to robust institutional ETF inflows and long-term accumulation as a floor, while bears are focused on potential macroeconomic fallout from prolonged conflict and the risk of a breakdown in technical support levels.

Algorand is a scalable, secure, and decentralized digital currency and smart contract platform. Its protocol uses a variation of Proof-of-Stake (PoS) called Pure PoS (PPoS) to secure the network and reach consensus on block production. Developers can build decentralized applications (dApps) using familiar programming languages, including Python, which Algorand supports natively. Its infrastructure enables various use cases, including payment systems, digital identity solutions, supply-chain tracking, and financial services. The protocol's architecture allows for tokenization of assets and the development of smart contracts, while its technical specifications support both retail users seeking basic transaction capabilities and enterprises requiring more, complex, blockchain solutions.

Algorand

Algorand is seeing heightened social engagement as the community reacts to a recent Google research paper that cites its protocol as a benchmark for quantum-resistant security, while investors remain split between long-term optimism regarding its enterprise utility and frustration over extended price volatility.

TON (The Open Network) is a general-purpose&nbsp;blockchain that allows developers to build decentralized apps and tokens.

Toncoin

Toncoin is capturing market attention as its integration with Telegram reaches a massive user base, with traders highlighting recent sub-second network upgrades and high APY staking opportunities. Community discussion is currently centered on increased institutional adoption, including new ETP listings and strategic whale accumulation despite recent price volatility.

statis crypto Watchlist

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

<ul class="summary-bullets"><li>The shareholder instead recommended that the company’s &nbsp;clinic business operate on a standalone basis.</li><li>Neuronetics on Monday reaffirmed its fiscal year 2026 guidance of revenue in the range of $160 million-$166 million and gross margin of 47% to 49%.&nbsp;</li><li>The company also said that Steven E. Pfanstiel will depart from his role as CFO to pursue an opportunity outside the company.</li></ul>Shares of Neuronetics Inc. (STIM) jumped as much as 16% after-hours on Monday before paring back gains after the firm’s largest independent shareholder called upon its board of directors to conduct a review of strategic alternatives, highlighting the company’s finite resources.Jorey Chernett, who owns about 14% of the company's outstanding shares, urged the board to consider options including the sale of its Transcranial Magnetic Stimulation (TMS) business unit under which it operates treatment centers across the U.S.The shareholder instead recommended that the company’s clinic business operate on a standalone basis. According to Chernett, the company has two compelling high-quality assets with expanding total addressable markets. The company also noted that the expected synergies of combining TMS and Greenbrook in December 2024 have not materialized thus far.“Since the December 2024 acquisition, pure-play peers have dramatically outperformed STIM and now trade at substantially higher multiples,” they said, while adding that the company has only finite resources which cannot serve both distinct businesses.<h2 class="st-heading-2">CFO Exit</h2>Neuronetics on Monday reaffirmed its fiscal year 2026 guidance of revenue in the range of $160 million to $166 million and gross margin of 47% to 49%.The company also said that Steven E. Pfanstiel will depart from his role as Chief Financial Officer (CFO) to pursue an opportunity outside the company. The company is now on the lookout for a replacement for Pfanstiel, who will remain with the company through May 1.<h2 class="st-heading-2">How Did Retail Traders React?</h2>On Stocktwits, retail sentiment around STIM stock jumped from ‘neutral’ to ‘bullish’ territory over the past 24 hours, while message volume increased from ‘normal’ to ‘high’ levels.<a href="https://stocktwits.com/symbol/STIM">STIM stock</a> has dropped 50% over the past 12 months.&nbsp;Read More: <a href="https://stocktwits.com/news-articles/markets/equity/orgo-stock-rallies-after-hours-on-clearing-regulatory-pathway-for-pain-relief-treatment/cZJ4yLURIYY">ORGO Stock Rallies After Hours On Clearing Regulatory Pathway For Pain Relief Treatment</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Rising stock market chart on a trading board background.

Why Is STIM Stock Rallying 16% After-Hours? 

STIM Stock - Neuronetics’ largest independent shareholder called upon its board of directors to conduct a review of strategic alternatives on Monday. 

Equity

Neuronetics’ largest independent shareholder called upon its board of directors to conduct a review of strategic alternatives on Monday. 


Largest Independent Shareholder of Neuronetics, Inc., Jorey Chernett, Calls for Immediate and Comprehensive Review of Strategic Alternatives, Including Sale of TMS Business

Largest Independent Shareholder of Neuronetics, Inc., Jorey Chernett, Calls for Immediate and Comprehensive Review of Strategic Alternatives, Including Sale of TMS Business Largest Independent...

William Andrew Macan Sells 16,005 Shares of Neuronetics (NASDAQ:STIM) Stock

Neuronetics, Inc. (NASDAQ:STIM - Get Free Report) EVP William Andrew Macan sold 16,005 shares of Neuronetics stock in a transaction that occurred on Thursday, March 19th. The shares were sold at an...

Neuronetics (NASDAQ:STIM) EVP Sells $21,446.70 in Stock

Neuronetics, Inc. (NASDAQ:STIM - Get Free Report) EVP William Andrew Macan sold 16,005 shares of Neuronetics stock in a transaction that occurred on Thursday, March 19th. The stock was sold at an...

Neuronetics (NASDAQ:STIM) EVP Steven Pfanstiel Sells 16,431 Shares

Neuronetics, Inc. (NASDAQ:STIM - Get Free Report) EVP Steven Pfanstiel sold 16,431 shares of Neuronetics stock in a transaction on Thursday, March 19th. The stock was sold at an average price of...

Neuronetics (NASDAQ:STIM) Director Sells $62,027.26 in Stock

Neuronetics, Inc. (NASDAQ:STIM - Get Free Report) Director Keith Sullivan sold 46,289 shares of Neuronetics stock in a transaction on Thursday, March 19th. The shares were sold at an average price of...

Neuronetics (NASDAQ:STIM) Major Shareholder Jorey Chernett Buys 169,472 Shares

Neuronetics, Inc. (NASDAQ:STIM - Get Free Report) major shareholder Jorey Chernett purchased 169,472 shares of the company's stock in a transaction that occurred on Friday, March 20th. The shares...

Insider Buying: Neuronetics (NASDAQ:STIM) Major Shareholder Buys $238,955.52 in Stock

Neuronetics, Inc. (NASDAQ:STIM - Get Free Report) major shareholder Jorey Chernett purchased 169,472 shares of the business's stock in a transaction on Friday, March 20th. The shares were purchased...

Insider Buying: Neuronetics (NASDAQ:STIM) Major Shareholder Buys 450,000 Shares of Stock

Neuronetics, Inc. (NASDAQ:STIM - Get Free Report) major shareholder Jorey Chernett acquired 450,000 shares of Neuronetics stock in a transaction that occurred on Thursday, March 19th. The stock was acquired at an average cost of $1.33 per share, with a total value of $598,500.00. Following the...

Neuronetics (NASDAQ:STIM) Stock Rating Lowered by Wall Street Zen

Wall Street Zen downgraded shares of Neuronetics from a "hold" rating to a "sell" rating in a research report on Saturday...

Neuronetics, Inc. is a commercial stage medical technology company, which focuses on designing, developing and marketing products that improve the quality of life for patients who suffer from neurohealth disorders. It operates through United States and International geographical segments. The company was founded by Steven B. Waite, Bruce J. Shook, Norman R. Weldon, and Thomas D. Weldon in 2003 and is headquartered in Malvern, PA.

STIM
Neuronetics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest STIM News

STIMNeuronetics Inc